A: Cu-Asp tetrakis-mu-acetylsalicylato-dicopper (II) MW: 844 B: Aspirin MW: 180 1869 YAKUGAKU ZASSHI 127(11) 1869-1875 (2007) The antiin‰ammatory eŠects of the copper-aspirin complex (Cu-Asp) were more potent than that of Asp in rats or mice with fewer classic adverse eŠects. The aim of this study was to determine the cause by evaluating Cu-Asp selective inhibition on cyclooxygenases (COX). COX-1 inhibition was evaluated based on 6-keto-prostaglandin F 1a (6-keto-PGF 1a ) in an endothelial cell model, and COX-2 inhibition was based on prostaglandin E 2 (PGE 2 ) in a macrophage model. Radioimmunoassay (RIA) was applied to determine 6-keto-PGF 1a in resting human umbilical vein endothelial cell line (ECV304), and PGE 2 in activated macrophages. The results showed that the inhibition of 6-keto-PGF 1a yield by Cu-Asp (3 to 0.01 mM) was markedly weaker than that by aspirin (Asp); while the inhibition of PGE 2 yield by Cu-Asp (10 to 0.1 mM) was signiˆcantly stronger than that by Asp. Based on the inhibition on 6-keto-PGF 1a and PGE 2 , the medium inhibitory concentration (IC 50 ) of Cu-Asp on COX-1 and on COX-2 was 1.03±0.15 mM, and 0.32±0.04 mM, respectively. The selective inhibition index on COX-2, IC 50 (COX-1)/IC 50 (COX-2), of CuAsp was 3.33±0.89, while that of Asp was 0.42±0.12. The results suggest that, unlike Asp, Cu-Asp is a relatively selective inhibitor of COX-2 in the present models; the selectivity of Cu-Asp is about seven-fold greater than that of Asp.
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INTRODUCTION
The copper-aspirin complex (Cu-Asp), tetrakismu-acetylsalicylato-dicopper (II), is a complex of aspirin (Asp) and copper ion (II) (Fig. 1) . 1, 2) Early studies 3, 4) and our recent studies 5, 6) indicated that the antiin‰ammatory eŠects of Cu-Asp were more potent than those of Asp in rats or mice, including 1) inhibiting ear swelling induced by xylene, 2) suppressing acute paw edema produced by injecting carrageenan, 3) decreasing wet weight and dry weight of pouch granuloma elicited by turpentine and nitrogen, and 4) decreasing the content of protein in the in‰ammatory exudate from air pouch synovitis caused by acetic acid and reducing leukocytes in the exudates. Moreover, Cu-Asp had fewer adverse eŠects, i.e., it seldom destroyed gastrointestinal mucosa. 4, 6, 7) Similarly, other transition metal aspirinates (mononuclear and binuclear transition metal [Co(II), Cu(II), Ni (II) and Zn(II)] acetylsalicylates) shared the activity pattern in antiin‰ammation. 3, 8) Asp is one of the classic nonsteroidal antiin‰ammatory drugs (NSADs), and its antiin‰ammatory activity is associated with cyclooxygenase ( COX ) inhibition directly or indirectly. 9) According to the results of recent research, there are at least three types of COX (COX-1, COX-2, and COX-3) involved in arachidonic acid (AA) metabolism. 10, 11) COX-1 was recognized as a constructive enzyme to maintain physiologic functions such as protecting the gastrointestinal mucosa; the activity of the COX-1 pathway can be measured by its downstream product 6-keto-PGF 1a . 12, 13) COX-3 is present in the central nervous system (CNS) or neural cells. 14) Both COX-1 and COX-3 have only a slight relationship with peripheral in‰ammation. However, COX-2 can be induced by various in‰ammatory stimuli, such as lipopolysaccharide (LPS), 15) phorbol 12-myristate 13-acetate (PMA), 16) and cytokines. 17) Prostaglandin E 2 (PGE 2 ), a metabolite of AA through the COX-2 pathway, is thought to be one of the key molecules involved in the in‰ammatory process. 18) The classic nonselective COX inhibitors like Asp and the newly developed COX-2 selective inhibitors are eŠective agents to quench, or help to quench, in‰ammation through the pathway. That is accepted as the main mechanism of NSADs.
Since the adverse eŠect of damage to the gastrointestinal mucosa by classical NSAIDs like Asp was believed to be caused by a physiologic PG decrease via COX-1 inhibition, 19 21) while the antiin‰ammatory activity of Cu-Asp is more potent than that of Asp with less frequent side eŠects, it could be assumed that there would be diŠerence in the inhibition of COX between Asp and Cu-Asp. However, the assumption was not conˆrmed. The present study was designed to evaluate the direct inhibitions of COX-1 and COX-2 based on diŠerent cell models to determine the mechanism.
MATERIALS AND METHODS

Materials
Healthy Culture of ECV304 Human umbilical vein endothelial cells, ECV-304, were incubated with RPMI 1640 containing 15％ fetal bovine serum in a CO 2 incubator at 37°C. When the cells covered about 80％ of the full area of the ‰ask, they were digested into disrupted cells with 0.25％ trypsin solution and harvested by spinning at 800×g for 10 min. The disrupted cells (1.0×10 5 /ml, 200 ml per well) were transplanted in to 96-well plates and incubated in the same conditions. When the cells adhered to the bottom (about 12 h), the above media were removed. The cells were rinsed twice with PBS, then exposed to Asp, Cu-Asp, CuSO 4 ＋Asp, and CuSO 4 , or exposed to 1％ pyridine (blank control for Cu-Asp). After incubation in the same conditions described above for 20 min, AA (10 mM) was added, and then incubated for another 20 min. The supernatant was collected as sample to determine levels of 6-keto-PGF 1a .
Culture of Mouse Macrophages ICR mice weighing 22 24 g were injected with 1％ starch broth 1 ml into the abdominal cavity. The next day, the mice were killed and disinfected with 75％ ethanol. The abdominal cavity was rinsed with 2 ml of PBS three times by injection. The PBS was collected, mixed, and spun for 5 min (800 rpm) to harvest macrophages. After cell identiˆcation, macrophages (1.0× 10 5 /ml, 200 ml per well) were transplanted into 96-well plates and incubated with RPMI 1640 containing 15％ fetal bovine serum and Asp 1.0 mM in a CO 2 incubator at 37°C overnight. Then, the macrophages were rinsed three times and induced with LPS (10 mg/ ml) for 18 h. The macrophages in every well were rinsed three times with PBS and exposed to Asp, CuAsp, CuSO 4 ＋Asp, and CuSO 4 , or exposed to 1％ pyridine. When the cells were incubated in the same conditions described above for 20 min, AA 10 mM was added. After incubation for another 20 min, the Cu-Asp inhibited COX-1 less powerfully than other groups; however, the inhibition caused by CuSO4 is the strongest. The inhibition of COX-1 is measured by the inhibition of 6-keto-PGF 1a yield in an endothelial cell (ECV304) model. The concentration is an equivalent dose for every group. Asp, aspirin; Cu-Asp, copper-aspirin complex supernatant was collected to determine levels of PGE 2 .
Radioimmunoassay for 6-keto-PGF 1a and PGE 2 Levels of 6-keto-PGF 1a or PGE 2 in the collected samples were determined using RIA kits according to the protocols provided by the manufacturer.
Absorption Bands of Cu-Asp, CuSO 4 ＋Asp, and CuSO 4 Cu-Asp, CuSO 4 ＋Asp, or CuSO 4 were dissolved in PBS. The equivalent concentration in all specimens was the same, while the pyridine in all specimens was controlled at 1％. The absorption bands were read with a spectrophotometer from 400 nm to 800 nm with an interval of 2 nm.
Mass Spectrograms of Cu-Asp and CuSO 4 ＋Asp Cu-Asp, CuSO 4 ＋Asp, or CuSO 4 were dissolved in PBS. The equivalent concentration in all specimens was the same, while the pyridine in all specimens was controlled at 1％. The mass spectrograms were scanned with a mass spectrometer (Shimadzu, Japan) in an electrospray ionization (ESI ＋ ) model from 750 m/z to 900 m/z.
Statistical Analyses
Values are expressed as mean±SD. One-way analysis of variance (ANOVA) was performed, and Hochberg's GT2 method of the post hoc test was performed to compare the means of diŠerent groups with that of the control group. Statistically signiˆcant diŠerences were accepted at p＜0.05. The concentration was transformed to logarithmic (Lg) value in statistical graphs.
Selective inhibition index of COX-2 was calculated according to formula 1 to evaluate selective inhibition. A greater index means more selective inhibition of COX-2.
Selective inhibition index of COX-2
RESULTS
EŠects of Cu-Asp on 6-keto-PGF1a Biosynthesis Asp, Cu-Asp, CuSO 4 ±Asp, and CuSO 4 inhibited 6-keto-PGF 1a biosynthesis in a concentration-dependent manner. At the highest concentration (10 mM), every group signiˆcantly inhibited 6-keto-PGF 1a synthesis. At other concentrations (3, 1, 0.3, and 0.1 mM), the inhibition of Cu-Asp was less powerful than that of Asp ( p＜0.05), while the inhibitory eŠects of CuSO 4 ＋Asp were similar to those of Asp ( p＞0.05) (Fig. 2, Table 1 ). The IC 50 of Cu-Asp on COX-1 was 1.03 ± 0.15 mM ( Table 1) .
EŠects of Cu-Asp on PGE 2 Formation
Asp, Cu-Asp, CuSO 4 ＋Asp, and CuSO 4 inhibited PGE 2 formation in a concentration-dependent manner. The inhibitory eŠects of Cu-Asp were much greater than those of Asp ( p＜0.05). Although the inhibitory eŠects of CuSO 4 ＋Asp were statistically greater than those of Asp ( p＜0.05) (Fig. 3) , its IC 50 value for COX-2 decreased relatively slightly ( Table 1) compared with the IC 50 value of Cu-Asp. There are some diŠerences among the absorbance patterns of Cu-Asp, CuSO4＋Asp, and CuSO4 from 400 nm to 800 nm, although they have a similar l max near 600 nm. However, the absorbance pattern of CuSO4＋ Asp is very similar to that of Cu-Asp. Asp 100 mM; Cu-Asp 25 mM; CuSO 4 ＋ Asp: mixture of CuSO4 50 mM and Asp 100 mM; CuSO4 50 mM In the two cell-based models, CuSO 4 only showed a mild inhibition of COX-1 and COX-2. Since the maximal inhibitory eŠect was less than 50％, its IC 50 value and selective inhibition index for COX-2 were not obtained.
Cu-Asp Transformation from Copper Sulfate and Asp
To determine how Cu-Asp is transformed from copper sulfate and Asp, the absorption bands of Cu-Asp, CuSO 4 ＋Asp, and CuSO 4 in PBS with 1％ pyridine were read with a spectrophotometer, as shown in Fig. 4 . Compared with that of CuSO 4 , the absorbance pattern of CuSO 4 ＋Asp is similar to that of Cu-Asp. The similarity could be caused by the transformation of Cu-Asp from CuSO 4 and Asp. This was conˆrmed by the mass spectrograms in the ESI ＋ model (Fig. 5) of Cu-Asp (Fig. 5 A) and CuSO 4 ＋Asp (Fig. 5 B) showing a spike near 848 m/ z, although the spike is lower in the spectrogram of CuSO 4 ＋Asp. The results suggest that it is possible to produce Cu-Asp from CuSO 4 and Asp in water solution.
DISCUSSION
As a classic NSAID, the antiin‰ammatory eŠects of Asp are achieved by inhibiting PGs synthesis via COX inhibition. Asp is a well-known nonselective COX inhibitor, and the IC 50 value for COX-1 and COX-2 is 0.75 and 1.25 mM in ovine cells, respectively. 22) Our early study and other studies found that Cu-Asp had an more powerful antiin‰ammatory eŠect than Asp with fewer adverse eŠects. 5, 6, 23) Since Cu-Asp is a derivate from Asp, the mechanism of action of CuAsp may be similar to that of Asp. According to the COX theory, it was assumed that Cu-Asp could also inhibit COX-2 even more selectively, and the present study veriˆed that hypothesis.
Cu-Asp Inhibits COX-2 More Selectively Without stimulation, endothelial cells mainly expresses COX-1, and PGI 2 is one of the main products via the enzyme, which can be quickly transformed to the stable substance 6-keto-PGF 1a . 18,24 26) COX-2 is an inducible enzyme mainly present in in‰ammatory cells including macrophages. With in‰ammatory stimulation, COX-2 expression is strongly upregulated. 18, 27) In the present study, the resting human umbilical vein endothelial cell line ECV304 was employed to study COX-1, while activated macrophages were employed to study COX-2. 6-Keto-PGF 1a and PGE 2 were used as indictors to measure COX-1 and COX-2 inhibition, respectively. 28, 29) Since the low quantity of endogenous AA could limit COX activity, 10 mM of exogenous AA was added into the reaction system. Asp can inhibit COX directly; furthermore, Asp can inhibit COX expression. 9) To study the direct COX inhibition by Asp and Cu-Asp, rather than to study COX expression inhibition, the preincubation time in the present study was 20 min. Models based on resting endothelial cells and activated macrophages, have been established to study selective inhibition of COX. 18, 25) The present results showed that the IC 50 value of Asp for COX-1 (0.56±0.11 mM) or COX-2 (1.36± 0.14 mM) is similar to the reported results (one sample Student t-test, p＞0.05). 22) The selective inhibition index of Asp for COX-2 is 0.42±0.12 (＜1), which supports the fact that Asp is a nonselective inhibitor of COX. 22) The results also showed that Cu-Asp inhibited COX-1 and COX-2 in a concentration-dependent manner with an IC 50 value of 1.03±0.20 mM for COX-1 and 0.32±0.05 mM for COX-2. The selective inhibition index for COX-2 is 3.22 (＞1), which suggests that Cu-Asp inhibits COX-2 more selectively than Asp, and its selectivity is about 8-fold that of Asp ( Table 1) . Therefore it can be deduced that the stronger antiin‰ammatory eŠects and fewer adverse eŠects may derive from its selective inhibition of COX-2. However, compared with classic COX-2 selective inhibitors, such as NS398 (IC 50 value for COX-1, 75 mM; IC 50 value for COX-2, 1.77 mM; selective index, 42 in humans) or celecoxib, the selectivity is not satisfactory. 30) Nevertheless, the phenomenon can explain the antiin‰ammatory eŠects in vivo and give an interesting clue to synthesize the ideal Asp derivative to quench in‰ammation.
Putative Mechanism of Cu-Asp Inhibition of COX COX-1 and COX-2 catalyze the same reaction and their proteins are similar in stereochemical structure. 31) There are three independent folding units in COX proteins, a surface domain, a membrane banding site, and an active domain in the stereostructure. The COX active site is composed of three spiral structures in the top of the hydrophobic channel that encaves into the cellular membrane. The channel is large in the active site and forms a cavity. In the side pocket towards the main channel in COX-1, a large amino acid, isoleucine 523, can block large molecules from the entrance to the side pocket, while in COX-2, a smaller hydrophilic amino acid, valine, stands at the site, and allows large molecules to pass into the entrance. COX-2 selective inhibitors, such as celecoxib and rofecoxib, which have a large sulfanilamide side chain in their structures, can bind to the hydrophilic side pocket and show selective inhibition of COX-2. As a small molecule, Asp can easily pass into both pockets in COX and inhibits COX by acetylating serine 530. 32) As a complex of Asp, the molecule Cu-Asp is larger than Asp (Fig. 1) and can not easily enter the side pocket of COX-1. In COX-2, however, CuAsp can pass the side pocket entrance and inhibited its active site.
In our experimental design, the amount of copper ion or Asp is equivalent to the Cu-Asp or CuSO 4 ＋ Asp group. However, the inhibition of COX-2 by CuSO 4 ＋Asp is also more potent than that by Asp. The copper ion (II) is amportant in Cu-Asp. The copper ion chelated in Cu-Asp is diŠerent from free copper ions. 1) In our experiments, it was found that the mixture of Asp1 mM and CuSO 4 0.5 mM in distilled water easily yields crystals with color almost identical to that of Cu-Asp crystals (Cu-Asp is not soluble in water). The hypothesis that the mixture of CuSO 4 and Asp could produce some Cu-Asp, since the absorbance pattern of CuSO 4 ＋Asp is similar to that of Cu-Asp was conˆrmed by the ESI ＋ mass spectra. That could be a reasonable explanation for the fact that CuSO 4 ＋Asp inhibited COX-2 more selectively than Asp but less selectively than Cu-Asp.
CONCLUSION
The antiin‰ammatory activity of Cu-Asp is more potent than that of Asp with fewer adverse eŠects in vivo, which is at least partly derived from its selective inhibition of COX-2. The selectivity of Cu-Asp is about seven-fold greater than that of Asp. Although more selective COX-2 inhibitors have been discovered, developed, and marketed, and although CuAsp may show fewer advantages in drug development, the present study at least gives a reasonable explanation for the antiin‰ammatory activity of CuAsp in vivo based on cell models. The results explain the antiin‰ammatory pharmacologic pattern of other transition metal aspinates.
